Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-10195.54%
↓ 112% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
82142.74%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -10195.54% | -101.2% |
| 2024 | 851675.00% | +7516.9% |
| 2023 | -11482.94% | -100.1% |
| 2022 | -5739.83% | -442.6% |
| 2021 | -1057.81% | -112.4% |
| 2020 | -498.12% | -6.3% |
| 2019 | -468.54% | -22.1% |
| 2018 | -383.59% | -58.0% |
| 2017 | -242.83% | -36.1% |
| 2016 | -178.39% | - |